Key Players in the Europe Antibody Production Market, Segmentation, Size, Shares and Revenue Analysis

Antibody production including different antibody production like monoclonal and polyclonal and others. This antibodies are ideally have core immune activity. The growing burden of different disease in Europe region is expected to drive the growth of antibody production in pharmaceutical and biotechnology companies, diagnostic laboratories, research institutes. In addition, rising rate of cancer and other disease has led the demand for the antibody production market. The market is expected to witness emerging growth in upcoming years.

To know the scope of our report get a sample on https://www.axiommrc.com/request-for-sample/10717-europe-antibody-production-market-report

MARKET DYNAMIC - EUROPE ANTIBODY PRODUCTION MARKET

The Europe market is significantly driven by rising incidence of infectious diseases in the region which has led the emerging demand for antibody production.  Besides, increasing adoption of targeted immunotherapy is anticipated to contribute in the region’s market. Also, increasing r&d expenditure in pharmaceutical and biotechnological companies to produce innovative antibody products based on different disease will accelerate the market growth. Likewise, rising number of fast track and orphan drug designations is likely to contribute healthy growth in the market.

COVID 19 IMPACT ON EUROPE ANTIBODY PRODUCTION MARKET REPORT

The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the Europe antibody production market. In addition, complete analysis of changes on the Europe antibody production market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. COVID-19 had a positive impact on market as the demand for the production of new antibody was accelerated specifically for corona viruses.

EUROPE ANTIBODY PRODUCTION MARKET SEGMENTAL OVERVIEW

The antibody production market comprises of different market segment like process, end user, class and geography.

EUROPE ANTIBODY PRODUCTION MARKET BY PROCESS 

The antibody production includes key process segment of upstream processing, downstream processing, ion exchange (iex) chromatography resins, hydrophobic interaction chromatography (hic) resins, multimodal chromatography resins, and filtration. Further, upstream processing includes bioreactors and consumables. Bioreactors is further sub segmented to large-scale bioreactors and single-use bioreactors (subs). Likewise, consumables includes media and reagents and buffers. Also, downstream processing is bifurcated to chromatography instruments and chromatography resins. Additionally filtration includes filtration systems and filtration consumables and accessories. The upstream processing is expected to witness growth at significant pace during the forecast period.  The growing productivity for production of antibody by upstream processing is the key driving factor the growth of segment. In addition, downstream processing is anticipated to emerge huge demand in upcoming years. The downstream processing significantly provides an advantage accuracy, and efficient product

EUROPE ANTIBODY PRODUCTION MARKET BY END USER

The antibody production market finds its end use in pharmaceutical and biotechnology companies, diagnostic laboratories and research institutes. The rising number of new pharmaceutical and biotechnology companies for the production of antibody is projected to propel the region’s market growth. Likewise, rising approval for antibody drugs in region’s market is boosting the segment growth.  In addition, diagnostic laboratories and research institutes are expected to witness emerging growth during the forecast period as number of research activities are conducted for the antibody production which is the key factor driving the market growth in region.

EUROPE ANTIBODY PRODUCTION MARKET BY CLASS

The antibody production by class is available in market according to monoclonal antibodies, murine, chimeric, humanized and polyclonal antibodies. Monoclonal antibodies is expected to grow at significant pace during the forecast period. The increasing adoption for the segment in Europe region is anticipated to drive the growth of market. Beside increasing research in different research institute and rising requirement for the production of the monoclonal antibodies is expected to boost the market growth. Additionally, polyclonal antibodies is estimated to contribute healthy growth in market during the forecast period. The growth is due to growing product production and application is likely to contribute in market growth. 

EUROPE ANTIBODY PRODUCTION MARKET BY COUNTRY

Europe antibody production market is studied for the following countries like Germany, U.K, France, Italy, Spain and Rest of Europe. Germany is expected to register major market for the Europe antibody production owing to emerging number of new manufacturer and rising demand for antibody production from various end use industries is expected to drive the growth of market. Besides, U.K followed by France are anticipated to register growth in positive way leading to growth of countries and ultimately boosting the Europe antibody production market

EUROPE ANTIBODY PRODUCTION MARKET KEY PLAYER

The key players in antibody production market are  GE Healthcare (General Electric Company), Merck KGAA, Thermo Fisher Scientific, Inc., Sartorius AG, Pall Corporation (Danaher Corporation), Sigma-Aldrich Corporation (Merck KGAA), Eppendorf AG, Cellab GmbH, Integra Biosciences AG and Fibercell Systems Inc. among others.

RECENT DEVELOPMENTS:

April 2021: Harbour BioMed had presented a newly discovered fully human anti- B7H7 monoclonal antibody at American Association for Cancer Research.  The anti- B7H7 monoclonal is a novel immune oncology antibody with potent anti-tumor activity generated using HBM proprietary H2L2 Harbour Mice platform

March 2021: Pionyr Immuno therapeutics had collaborated with Lonza to support the oncology product development. The collaboration will bring the Pionyr third pipeline development candidate for novel Myeloid Tuning target to clinical development. Also, Lonza Company will provide cell line development, process development, drug substance and drug product manufacturing for Pionyr’s monoclonal antibody candidate intended for oncology indications. 

November 2020: Purolite Ltd had announced that the company will supply its protein A capture resin, Praesto Jetted A50 to WuXi Biologics for immediate use. The WuXi Biologics company will use the Praesto Jetted A50 to provide their customer for affinity chromatography resin for range of downstream processing for monoclonal antibody purification.

October 2020: IAVI and Serum Institute of India had announced an agreement with Merck KGaA, Germany to develop SARS CoV-2 neutralizing monoclonal antibodies (mAbs) and is co- invented by IAVI and Scripps Research as innovative interventions for COVID-19 pandemic.

Buy now Europe Antibody Production Market Report https://www.axiommrc.com/buy_now/10717-europe-antibody-production-market-report

About Us:

Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc. 

Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.

Axiom MRC with its experienced team of research and data analysts, has delivered more than 5000+ Market Research Projects, 3800+ Data Analytics Projects, 1200+ Business Support Projects and has a 800+ Global Client Base. Axiom Market Research & Consulting™ aims to become the preferred market research and data analytics company by providing key market intelligence solutions for client’s business growth.

Contact Us:

Axiom Market Research & Consulting™

3 Germay Dr. Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: sales@axiommrc.com

Website: https://www.axiommrc.com/

Blog: https://industrywatch24.com/

          https://readbeyondnews.com/

Follow On

LinkedIn: https://www.linkedin.com/company/axiom-market-research-and-consulting/

Twitter:  https://twitter.com/AxiommrcCom

Comments

Post a Comment

Popular posts from this blog

Induced Pluripotent Stem Cells Market is anticipated to grow at a CAGR of 7.32% from 2022 to 2028

Image
Global Induced Pluripotent Stem Cells Market research report provides comprehensive information on the market. It also includes in-depth information about Market #Drivers, Opportunities, Market Restraints, Market Growth #Challenges and Cumulative #Growth Analysis. Moreover, the report also provides an in-depth analysis of the Induced Pluripotent Stem Cells Market by identifying key players. The report also examines the #competitive landscape of the Induced Pluripotent Stem Cells Market industry and analyses its impact on the growth of this market over the next few years. The segmental analysis focuses on revenue and forecast for the period 2019-2028.   Request PDF Sample Copy of Report @ https://www.axiommrc.com/request-for-sample/11226-induced-pluripotent-steam-cells-market-report   Axiom Market Research & Consulting™ added a report on Global Induced Pluripotent Stem Cells Market which includes study on derived cell type, product, process, application, end ...
Read more

Freeze Drying Equipment Market: Growth, Opportunities, and Future Outlook

Freeze Drying Equipment Market is segmented based on type, application, and region. The different types of freeze drying equipment include laboratory, pilot, and industrial-scale equipment. The applications of freeze drying equipment include food processing, pharmaceuticals, biotechnology, and others. The market is dominated by the pharmaceutical and biotechnology segments due to the high demand for freeze-dried drugs and vaccines.   Freeze drying, also known as lyophilization, is a dehydration process used to preserve perishable materials such as food, pharmaceuticals, and biologicals. Freeze drying equipment is used to carry out this process, which involves freezing the material and then removing the ice by sublimation. Freeze drying equipment is an essential tool for industries that require long-term storage of perishable materials. The global freeze drying equipment market is expected to grow at a significant rate in the coming years due to the increasing demand for freeze...
Read more

Future of Europe Infection Surveillance Solutions Market in 2022-2028

Image
Infection surveillance solutions are used to reduce several healthcare associated infections such as pneumonia (eg, ventilator-associated pneumonia [VAP]), bloodstream infection (BSI), urinary tract infection (UTI), and surgical site infection (SSI). It is also used to reduce other infections such as surgical wound infections, respiratory tract infections, and many others. A healthcare-associated infection is an infection whose development is favored by a hospital or other healthcare facilities environment, such as one acquired by a patient during a hospital visit To know the scope of our report get a sample  on https://www.axiommrc.com/request-for-sample/11021-europe-infection-surveillance-solutions-market-report MARKET DYNAMIC- EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET Primary driving factors such as the vast presence of developing as well as developed economies, increasing funding for improving the healthcare infrastructure and redevelopment of healthcare projects and s...
Read more